Autophagy plays an important role in the containment of HIV-1 in nonprogressor-infected patients
Citations Over TimeTop 10% of 2014 papers
Abstract
Recent in vitro studies have suggested that autophagy may play a role in both HIV-1 replication and disease progression. In this study we investigated whether autophagy protects the small proportion of HIV-1 infected individuals who remain clinically stable for years in the absence of antiretroviral therapy, these named long-term nonprogressors (LTNP) and elite controllers (EC). We found that peripheral blood mononuclear cells (PBMC) of the HIV-1 controllers present a significantly higher amount of autophagic vesicles associated with an increased expression of autophagic markers with respect to normal progressors. Of note, ex vivo treatment of PBMC from the HIV-1 controllers with the MTOR inhibitor rapamycin results in a more efficient autophagic response, leading to a reduced viral production. These data lead us to propose that autophagy contributes to limiting viral pathogenesis in HIV-1 controllers by targeting viral components for degradation.
Related Papers
- → There is more to autophagy than induction(2011)4 cited
- Roles of autophagy in lymphocytes： reflections and directions(2010)
- Death and survival of neuronal and astrocytic cells in ischemic brain injury： a role of autophagy(2011)
- → Is Selective Autophagy Distinct from Starvation-Induced Autophagy?(2016)
- Autophagy in cancer biology and therapy(2014)